Tectonic Therapeutic, Inc. — Director's Dealing 2019

Jul 30, 2019

SEC Form 4/A — Form 4/A

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2019-07-19

Reporting Person: Atlas Venture Fund X, L.P. (10% Owner)
Reporting Person: ATLAS VENTURE ASSOCIATES X, L.P. (10% Owner)
Reporting Person: Atlas Venture Associates X, LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4756478	Indirect

Footnotes

F1: The shares are held directly by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. ("AVA X LP"). Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. Each of AVA X LP and AVA X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of its pecuniary interest therein, if any.